10/31/2026
The 2026 update to the American Society of Clinical Pathology (ASCP) and College of American Pathologists (CAP) guideline HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma.
Today, we're taking a look at the 2026 update to the American Society of Clinical Pathology (ASCP) and College of American Pathologists (CAP) guideline HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma.